Apogee Therapeutics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Apogee Therapeutics, Inc. (APGE) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.50 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2024-11-12
- Apogee Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-09-30 was $1.50M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month |
|---|---|
| 2023-09-30 | $1.50M 10-Q · filed 2024-11-12 |